Biotech · Private company
GB002, Inc.
Track this companyFree. Adds GB002, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- Generic Dry Powder InhalerPhase 3 · Pulmonary Arterial HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- Generic Dry Powder InhalerPhase 3 · Pulmonary Hypertension Associated With Interstitial Lung DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- SeralutinibPhase 3 · Pulmonary Arterial HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- SeralutinibPhase 3 · Pulmonary Hypertension Associated With Interstitial Lung DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Efficacy and Safety of Seralutinib in Adult Subjects With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)PHASE3 · SUSPENDED · started Feb 1, 2026ClinicalTrials.gov NCT07181382 · fetched Nov 12, 2026
- Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)PHASE3 · COMPLETED · started Dec 28, 2023ClinicalTrials.gov NCT05934526 · fetched Nov 12, 2026